Assessment of Maternity Nurses' Staff Perception and Practice Regarding Anti Phospholipids Syndrome

Abstract

Antiphospholipid Syndrome (APS), also known as Hughes Syndrome, The syndrome is characterized by recurrent thromboembolic events and pregnancy loss in the presence of persistent laboratory evidence for antiphospholipid antibodies (aPLs)- lupus anticoagulant, anticardiolipin antibodies, and anti-B2 glycoprotein I antibodies (Oretel, 2012). It is estimated that APS may be responsible for nearly one -third of cerebrovascular accidents in people under age 50 years, one- fifth of all cases of deep vein thrombosis, and one -fourth of recurrent miscarriages. In its most life-threatening form, catastrophic APS carries a mortality of 30-50%, even with treatment (Erkan & Pierangeli, 2012). Perinatal nurses often care for pregnant women with APS who require treatment, education, and support. Because of the prevalence of aPL antibodies and their associated adverse pregnancy outcomes, it is imperative that nurses are aware of APS, its risks, associated complications, medical treatment, and nursing management. Without this knowledge, nurses may fail to overlook changes indicating pregnancy complications. Likewise, nurses may not adequately educate the clients and the clients’ families regarding prevention and management of APS complications (Gabrielle & Deneen, 2013).